Novel Triazolopyrimidine-Derived Cannabinoid Receptor 2 Agonists as Potential Treatment for Inflammatory Kidney Diseases-Reference-Cited by-同舟云学术

Novel Triazolopyrimidine-Derived Cannabinoid Receptor 2 Agonists as Potential Treatment for Inflammatory Kidney Diseases

Published:2015-07-21 Issue:2 Volume:11 Page:179-189
ISSN:1860-7179
Container-title:ChemMedChem
language:en
Short-container-title:ChemMedChem

Author:

Nettekoven Matthias¹,Adam Jean-Michel¹,Bendels Stefanie¹,Bissantz Catarina¹,Fingerle Jürgen²,Grether Uwe¹,Grüner Sabine²,Guba Wolfgang¹,Kimbara Atsushi¹,Ottaviani Giorgio³,Püllmann Bernd¹,Rogers-Evans Mark¹,Röver Stephan¹,Rothenhäusler Benno³,Schmitt Sebastien¹,Schuler Franz³,Schulz-Gasch Tanja¹,Ullmer Christoph²

Affiliation:

1. Roche Pharmaceutical Research and Early Development; Small-Molecule Research; Roche Innovation Center Basel; Grenzacher Str. 124 4070 Basel Switzerland

2. Roche Pharmaceutical Research and Early Development; Discovery Biology; Roche Innovation Center Basel; Grenzacher Str. 124 4070 Basel Switzerland

3. Roche Pharmaceutical Research and Early Development, DMPK; Roche Innovation Center Basel; Grenzacher Str. 124 4070 Basel Switzerland

Publisher

Wiley

Subject

Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics,Molecular Medicine,Drug Discovery,Biochemistry,Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cmdc.201500218/fullpdf

Reference58 articles.

1. Is lipid signaling through cannabinoid 2 receptors part of a protective system?

2. Modulation of the Endocannabinoid System in Cardiovascular Disease

3. Cannabinoids and the gut: New developments and emerging concepts

4. CB2 receptors as new therapeutic targets for liver diseases

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enzyme-Catalyzed Regioselective Synthesis of 4-Hetero-Functionalized 1,5-Disubstituted 1,2,3-Triazoles;Organic Letters;2024-09-04

2. From mundane to surprising nonadditivity: drivers and impact on ML models;Journal of Computer-Aided Molecular Design;2024-07-25

3. RG7774 (Vicasinabin), an orally bioavailable cannabinoid receptor 2 (CB2R) agonist, decreases retinal vascular permeability, leukocyte adhesion, and ocular inflammation in animal models;Frontiers in Pharmacology;2024-07-12

4. A Highly Potent, Orally Bioavailable Pyrazole-Derived Cannabinoid CB2 Receptor- Selective Full Agonist for In Vivo Studies;ACS Pharmacology & Translational Science;2024-07-09

5. Cu(II)/PTABS-Promoted, Chemoselective Amination of HaloPyrimidines;The Journal of Organic Chemistry;2024-06-15